Table 2.
Event | Pioglitazone (n = 8) | Placebo (n = 8) |
---|---|---|
Abdominal pain | 0 | 1 |
Abnormal glucose | 1 | 0 |
Abnormal platelet count | 1 | 0 |
Acne | 0 | 1 |
Anxiety | 0 | 1 |
Asthma exacerbation by viral infection | 1a | 0 |
Bloating | 1 | 0 |
Blood in stool | 0 | 1 |
Blurred vision | 0 | 1 |
Buzzed | 1 | 0 |
Chills | 0 | 1 |
Cold-like symptoms | 0 | 3 |
Dark urine | 0 | 1 |
Deep vein thrombosis | 1a | 0 |
Elevated aspartate aminotransferase | 1 | 0 |
Elevated creatine kinase | 5b | 1 |
Fatigue | 0 | 1 |
Fever | 1 | 0 |
Frequent urination | 0 | 1 |
Headache | 2 | 4 |
Irritability | 0 | 1 |
Itching | 1 | 1 |
Lightheaded | 1 | 1 |
Loss of appetite | 2 | 0 |
Low red blood count/hemoglobin A1C | 1 | 0 |
Muscle aches | 1 | 3 |
Muscle tightness | 0 | 1 |
Nausea | 1 | 2 |
Neck pain | 1 | 0 |
Pain | 2 | 0 |
Pain in extremity | 1 | 0 |
Phlebitis | 0 | 1 |
Sinus pain | 0 | 2 |
Sleepiness | 1 | 1 |
Sore throat | 2 | 2 |
Stomach pain | 1 | 1 |
Tiredness | 5 | 5 |
Toothache | 1 | 3 |
Trouble sleeping | 1 | 0 |
Reported as a serious adverse event
One occurrence reported as a serious adverse event